Microbix Biosystems Inc T.MBX

Alternate Symbol(s): MBXBF

Healthcare Biotechnology

Microbix Biosystems Inc. develops and commercializes biological and technological solutions for human health and wellbeing. It enables the commercialization of diagnostic assays by making a range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency testing, enable assay development and validation, or help ensure the quality of clinical diagnostic workflows. Its segments include development, manufacturing and sales of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows and viral transport medium to enable collection of patient test samples and, and development and commercialization of novel and proprietary products or technologies, such as Kinlytic. Its Kinlytic urokinase is a biologic thrombolytic drug used to treat blood clots.

TSX:MBX - Post by User

Microbix Biosystems Inc > YEAR LOW

<< Previous

Bullboard Posts

Next >>

Comment by wizzdumbon Feb 01, 2023 6:04pm

134 Views

Post# 35260886

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:YEAR LOW

Agree. May continue to drift down in half cent increments and low volumes in the absence of any formal news. Majority of these shares are being bought back by the company and cancelled so no big deal unless you absolutely need to sell your own which would suck. Fundamentals still stronger than ever and it's just a timing game now, don't miss out when it pops on news as it will go fast and furious likely.

<< Previous

Bullboard Posts

Next >>

How one company is disrupting PoC testing